DERMATA THERAPEUTICS, INC.

DRMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Mar 17, 2026 4
8-K Feb 25, 2026 8-K
SCHEDULE 13D/A Feb 23, 2026
SCHEDULE 13G/A Feb 18, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 9, 2026
8-K Feb 3, 2026 8-K
SCHEDULE 13D/A Feb 2, 2026
EFFECT Jan 29, 2026
424B3 Jan 29, 2026 424B3
CORRESP Jan 27, 2026
UPLOAD Jan 27, 2026
8-K Jan 27, 2026 8-K
424B5 Jan 27, 2026 424B5
S-3 Jan 22, 2026 S-3
SCHEDULE 13D/A Jan 8, 2026
D Jan 7, 2026
4 Jan 6, 2026
4 Jan 6, 2026
4 Jan 6, 2026 4
4 Jan 6, 2026
4 Jan 6, 2026 4
4 Jan 6, 2026
4 Jan 6, 2026 4
4 Jan 6, 2026 4
← Newer Page 2 of 15 · 366 filings Older →